Document is current
Any future updates will be listed below
-
Authors
Apostol, Adriana Ionelia https://orcid.org/0009-0008-4614-9261
Bruno, Matteo https://orcid.org/0000-0003-4372-4220
Sassu, Carolina Maria https://orcid.org/0000-0002-1702-5859
Boccia, Serena Maria https://orcid.org/0009-0008-4677-469X
Vertechy, Laura https://orcid.org/0000-0002-1155-3888
Russo, Giorgia https://orcid.org/0009-0004-1233-9850
Ruscito, Ilary https://orcid.org/0000-0002-2586-832X
Capomacchia, Filippo Maria https://orcid.org/0000-0002-5509-4193
Scambia, Giovanni https://orcid.org/0000-0002-9503-9041
Fagotti, Anna https://orcid.org/0000-0001-5579-335X
Marchetti, Claudia https://orcid.org/0000-0001-7098-8956
-
Funding
Funding for this research was provided by:
Università Cattolica del Sacro Cuore
- License Information
-
More Information
Article History
Received: 4 August 2025
Accepted: 25 October 2025
First Online: 4 November 2025
Declarations
:
: CM is on the consultant/advisory board for Clovis, Pharmamar, GSK, AstraZeneca and MSD, and received travel accommodation from Pharmamar and Roche. AF reports commercial interests with AstraZeneca, MSD, Johnson & Johnson and Pharmamar. GS reported research support from MSD and honoraria from Clovis Oncology, and he was a consultant for GSK, Tesaro and Johnson & Johnson. SMB is on the consultant/advisory board for GSK, AstraZeneca and Pharmamar. All the other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
: This study involves human participants and was approved by Comitato Etico Territoriale Lazio Area 3, Fondazione Policlinico A. Gemelli (IRCCS ID: 6356). Participants gave informed consent to participate in the study before taking part.
: Informed consent was obtained from all individual participants included in the study.
